![]() N-Methyl-N-{3-[({2-[(2-oxo-2,3-dihydro-1H-indol-6-yl)amino]-5-(tr ifluoromethyl)-4-pyrimidinyl}amino)methyl]-2-pyridinyl}methanesul fonamide methanesulfonate (1:1) structure
|
Common Name | N-Methyl-N-{3-[({2-[(2-oxo-2,3-dihydro-1H-indol-6-yl)amino]-5-(tr ifluoromethyl)-4-pyrimidinyl}amino)methyl]-2-pyridinyl}methanesul fonamide methanesulfonate (1:1) | ||
---|---|---|---|---|
CAS Number | 939791-39-6 | Molecular Weight | 603.59400 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C22H24F3N7O6S2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Name | N-Methyl-N-{3-[({2-[(2-oxo-2,3-dihydro-1H-indol-6-yl)amino]-5-(tr ifluoromethyl)-4-pyrimidinyl}amino)methyl]-2-pyridinyl}methanesul fonamide methanesulfonate (1:1) |
---|---|
Synonym | More Synonyms |
Molecular Formula | C22H24F3N7O6S2 |
---|---|
Molecular Weight | 603.59400 |
Exact Mass | 603.11800 |
PSA | 207.06000 |
LogP | 4.38210 |
~% N-Methyl-N-{3-[... CAS#:939791-39-6 |
Literature: Pfizer Inc. Patent: US2011/33441 A1, 2011 ; |
~% N-Methyl-N-{3-[... CAS#:939791-39-6 |
Literature: Pfizer Inc. Patent: US2011/33441 A1, 2011 ; |
~% N-Methyl-N-{3-[... CAS#:939791-39-6 |
Literature: Pfizer Inc. Patent: US2011/33441 A1, 2011 ; |
N-methyl-N-(2-trimethylacetoxyethyl)oleamide |
N-methyl-N-(3-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethylpyrimidin-4-ylamino]methyl}pyridin-2-yl)methanesulfonamide monomesylate |